Targeted next-generation sequencing of cancer-related genes in thyroid carcinoma: A single institution's experience (Q90465843)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

title

Targeted next-generation sequencing of cancer-related genes in thyroid carcinoma: A single institution's experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

Nobuyuki Bandoh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Toshiaki Akahane

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Takashi Goto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Michihisa Kono

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Haruyuki Ichikawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Takahiro Sawada

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Tomomi Yamaguchi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Hiroshi Nakano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Yumiko Kawase

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Yasutaka Kato

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Hajime Kamada

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Yasuaki Harabuchi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Kazuo Shimizu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Hiroshi Nishihara

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

publication date

2 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

7278-7286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

Mutations of the BRAF gene in human cancer

14 April 2020

cites work

1 reference

12 December 2020

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma

1 reference

12 December 2020

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

1 reference

12 December 2020

Oncogenic mutations of PIK3CA in human cancers

1 reference

12 December 2020

Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis

1 reference

12 December 2020

The BRAFV600E mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma

1 reference

12 December 2020

Mutation of the PIK3CA oncogene in human cancers

1 reference

12 December 2020

Pathogenetic mechanisms in thyroid follicular-cell neoplasia

1 reference

12 December 2020

Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.

1 reference

12 December 2020

Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling.

1 reference

12 December 2020

BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation

1 reference

12 December 2020

Epidermal growth factor receptor status in anaplastic thyroid carcinoma

1 reference

12 December 2020

Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion

1 reference

12 December 2020

Epidermal growth factor receptor mutations in lung cancer

1 reference

12 December 2020

Radiation-induced thyroid cancer: what we have learned from chernobyl

1 reference

12 December 2020

Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach

1 reference

12 December 2020

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

1 reference

12 December 2020

Clinical significance of BRAF (V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas

1 reference

12 December 2020

EGFR antagonists in cancer treatment

1 reference

12 December 2020

Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer.

1 reference

12 December 2020

Possible involvement of BRAFV600E in altered gene expression in papillary thyroid cancer

1 reference

12 December 2020

Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAF(V600E) mutation

1 reference

12 December 2020

Epidermal growth factor receptor gene mutations in papillary thyroid carcinoma

1 reference

12 December 2020

Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin

1 reference

12 December 2020

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing

1 reference

12 December 2020

Relative quantification of PIK3CA gene expression level in fine-needle aspiration biopsy thyroid specimens collected from patients with papillary thyroid carcinoma and non-toxic goitre by real-time RT-PCR.

1 reference

12 December 2020

Molecular analysis of thyroid tumors

1 reference

12 December 2020

The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.

1 reference

12 December 2020

BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients.

1 reference

12 December 2020

The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study

1 reference

12 December 2020

Clinical significance of BRAF mutation in thyroid papillary cancer

1 reference

12 December 2020

Clinicopathologic implications of the BRAF(V600E) mutation in papillary thyroid cancer: a subgroup analysis of 3130 cases in a single center.

1 reference

12 December 2020

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

1 reference

12 December 2020

The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis

1 reference

12 December 2020

Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers

1 reference

12 December 2020

Postnatal expression of BRAFV600E does not induce thyroid cancer in mouse models of thyroid papillary carcinoma.

1 reference

12 December 2020

Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer

1 reference

12 December 2020

BRAF(V600E) mutation analysis in papillary thyroid carcinoma: is it useful for all patients?

1 reference

12 December 2020

Association between expression of X-linked inhibitor of apoptosis protein and the clinical outcome in a BRAF V600E-prevalent papillary thyroid cancer population

1 reference

12 December 2020

Sequencing depth and coverage: key considerations in genomic analyses

1 reference

12 December 2020

Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing

1 reference

12 December 2020

Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

1 reference

12 December 2020

A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing

1 reference

12 December 2020

BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review

1 reference

12 December 2020

Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancer

1 reference

12 December 2020

BRAF(V600E) Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis

1 reference

12 December 2020

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.

1 reference

12 December 2020

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients

1 reference

12 December 2020

Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area

1 reference

12 December 2020

B-Raf mutation and papillary thyroid carcinoma patients

1 reference

12 December 2020

Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA.

1 reference

12 December 2020

The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review

1 reference

12 December 2020

Next-generation sequencing in thyroid cancer

1 reference

12 December 2020

Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer

1 reference

12 December 2020

Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes

1 reference

12 December 2020

Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area

1 reference

12 December 2020

Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?

1 reference

12 December 2020

Altered molecular profile in thyroid cancers from patients affected by the Three Mile Island nuclear accident

1 reference

12 December 2020

Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.

1 reference

12 December 2020

Targeted next-generation sequencing of cancer genes in poorly differentiated thyroid cancer.

1 reference

12 December 2020

Genetic landscape of papillary thyroid carcinoma in the Chinese population.

1 reference

12 December 2020

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis.

1 reference

12 December 2020

Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.

1 reference

12 December 2020

Identifiers

DOI

10.3892/OL.2018.9538

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30546467%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference